drugset / Trial / NCT05638828
A Study of RD14-01 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety and tolerability of RD14-01, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ advanced solid tumors.
Timeline
- Start
- 2022-12-01
- Primary completion
- 2023-12-01
- Completion
- 2024-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RD14-01 | Cell therapy | — | — |